EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

Hervé Avet-Loiseau iD, Faith E Davies iD, Mehmet K Samur iD, Jill Corre iD, Mattia D'Agostino iD, Martin F Kaiser iD, Marc S Raab iD, Niels Weinhold iD, Norma C Gutierrez iD, Bruno Paiva iD, Paola Neri, Katja Weisel iD und 34 weitere

Journal of Clinical Oncology · 20.08.2025 · 43 (24) · 2739-2751

DOI: 10.1200/jco-24-01893 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.08.2025. Verfasst von Hervé Avet-Loiseau und 45 weiteren Autor:innen. Beteiligte Einrichtung: Unité de Genomique du Myélome, Institut National de la Santé et de la Recherche Médicale, University Cancer Center of Toulouse, Toulouse, France. Hauptthemen laut MEDLINE: Multiple Myeloma. Die Arbeit wurde bisher 214-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite significant improvements in survival of patients with multiple myeloma (MM), outcomes remain heterogeneous, and a significant proportion of patients experience suboptimal outcomes. Importantly, traditional prognostic factors based on data from patients treated with older therapies no longer capture prognosis accurately in the contemporary era of novel triplet or quadruplet therapies. Therefore, risk stratification requires refinement in the context of available and investigational treatment options in routine practice and clinical trials, respectively. The current identification of high-risk MM (HRMM) in routine practice is based on the Revised International Staging System, which stratifies patients using a combination of widely available serum biomarkers and chromosomal abnormalities assessed via fluorescence in situ hybridization. In recent years, a substantial body of evidence concerning additional clinical, biological, and molecular/genomic prognostic factors has accumulated, along with new MM risk stratification tools and consensus reports. The International Myeloma Society, along with the International Myeloma Working Group, convened an Expert Panel with the primary aim of revisiting the definition of HRMM and formulating a practical and data-driven consensus definition, based on new evidence from molecular/genomic assays, updated clinical data, and contemporary risk stratification concepts. The Panel proposes the following Consensus Genomic Staging (CGS) of HRMM which relies upon the presence of at least one of these abnormalities: (1) del(17p), with a cutoff of >20% clonal fraction, and/or TP53 mutation; (2) an IgH translocation including t(4;14), t(14;16), or t(14;20) along with 1q+ and/or del(1p32); (3) monoallelic del(1p32) along with 1q+ or biallelic del(1p32); or (4) β2 microglobulin ≥5.5 mg/L with normal creatinine (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHumansRisk AssessmentNeoplasm StagingPrognosisBiomarkers, TumorChromosome Aberrations

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Unité de Genomique du Myélome, Institut National de la Santé et de la Recherche Médicale, University Cancer Center of Toulouse, Toulouse, France.
  • Perlmutter Cancer Center, NYU Langone Health, New York, NY.
  • Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Division of Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
  • University of Torino and Department of Molecular Biotechnology and Health Sciences, Torino, Italy.
  • Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.

ORCID-Profile: Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, Jill Corre, Mattia D'Agostino, Martin F Kaiser, Marc S Raab, Niels Weinhold, Norma C Gutierrez, Bruno Paiva, Katja Weisel, Francesco Maura, Brian A Walker, Mark Bustoros, A Keith Stewart, Saad Z Usmani, Jens Hillengass, Wee Joo Chng, Jonathan J Keats, Joaquin Martinez-Lopez, Adam S Sperling, Cyrille Touzeau, Fenghuang Zhan, Noopur S Raje, Niccolò Bolli, Irene M Ghobrial, Madhav V Dhodapkar, Sundar Jagannath, Andrew Spencer, Samir Parekh, Nizar J Bahlis, Pieter Sonneveld, Leif Bergsagel, Robert Z Orlowski, María Victoria Mateos, Jesus F San Miguel, Kenneth C Anderson, Philippe Moreau, Shaji Kumar, Nikhil C Munshi

Förderung

  • NCI NIH HHS

Zitieren

APA

Avet-Loiseau, H., Davies, F. E., Samur, M. K., Corre, J., D'Agostino, M., Kaiser, M. F., Raab, M. S., Weinhold, N., Gutierrez, N. C., Paiva, B., Neri, P., Weisel, K., Maura, F., Walker, B. A., Bustoros, M., Stewart, A. K., Usmani, S. Z., Hillengass, J., Chng, W. J., …, & Munshi, N. C. (2025). International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma. Journal of Clinical Oncology, 43(24), 2739-2751. https://doi.org/10.1200/jco-24-01893

Vancouver

Avet-Loiseau H, Davies FE, Samur MK, Corre J, D'Agostino M, Kaiser MF, et al. International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma. Journal of Clinical Oncology. 2025;43(24):2739-2751. doi:10.1200/jco-24-01893

BibTeX
@article{AvetLoiseau2025,
  author = {Avet-Loiseau, Hervé and Davies, Faith E and Samur, Mehmet K and Corre, Jill and D'Agostino, Mattia and Kaiser, Martin F and Raab, Marc S and Weinhold, Niels and Gutierrez, Norma C and Paiva, Bruno and Neri, Paola and Weisel, Katja and Maura, Francesco and Walker, Brian A and Bustoros, Mark and Stewart, A Keith and Usmani, Saad Z and Hillengass, Jens and Chng, Wee Joo and Keats, Jonathan J and Martinez-Lopez, Joaquin and Sperling, Adam S and Touzeau, Cyrille and Zhan, Fenghuang and Raje, Noopur S and Cavo, Michele and Bolli, Niccolò and Ghobrial, Irene M and Dhodapkar, Madhav V and Jagannath, Sundar and Spencer, Andrew and Parekh, Samir and Bahlis, Nizar J and Lonial, Sagar and Sonneveld, Pieter and Bergsagel, Leif and Orlowski, Robert Z and Morgan, Gareth and Mateos, María Victoria and Rajkumar, S Vincent and San Miguel, Jesus F and Anderson, Kenneth C and Moreau, Philippe and Kumar, Shaji and Prósper, Felipe and Munshi, Nikhil C},
  title = {International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma},
  journal = {Journal of Clinical Oncology},
  year = {2025},
  volume = {43},
  number = {24},
  pages = {2739--2751},
  doi = {10.1200/jco-24-01893}
}
Kostenlos starten →